10th Annual Conference on Stem Cell and Regenerative Medicine (CSE) S
08:00 - 17:00
10th Annual Conference on Stem Cell and Regenerative Medicine
Conference Series LLC LTD invites all the participants from all over the world to attend "10th Annual Conference on Stem Cell and Regenerative Medicine" during October 08-09, 2018 at Zurich, Switzerland which includes prompt keynote presentations, oral talks, poster presentations, networking, and exhibitions.
Stem cells are cells originate in all multi-cellular organisms. They were isolated in mice in 1981 and in humans in 1998. In humans, there are several types of stem cells, each with varying levels of potency. Stem cell treatments are a type of cell therapy that introduces new cells into adult bodies for possible treatment of cancer, diabetes, neurological disorders and other medical conditions. Stem cells have been used to repair tissue damaged by disease or age. Currently, it has emerged as a rapidly diversifying field with the potential to address the worldwide organ shortage issue and comprises of tissue regeneration and organ replacement. The global tissue engineering and regeneration market reached $17 billion in 2013. This market is expected to grow to nearly $20.8 billion in 2014 and $56.9 billion in 2019, a compound annual growth rate (CAGR) of 22.3%. On the basis of geography, Europe holds the second place in the global market in the field of regenerative medicine & tissue engineering. In Europe countries like the UK, France and Germany are possessing good market shares in the field of regenerative medicine and tissue engineering. Spain and Italy are the emerging market trends for tissue engineering in Europe.
Stem Cell Congress-2018 has the goal to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. Annual Conference on Stem Cell Congress 2018 will have an anticipated participation of 150+ delegates across the world to discuss the conference goal.
Conference Series LLC LTD is one of the leading Open Access publishers and organizers of international scientific conferences and events every year across the USA, Europe & Asia Conference Series LLC LTD has so far organized 300+ International Conferences across the World with 500+ peer-reviewed open access journals in basic science, health, and technology. Conference Series LLC LTD is also in association with more than 1000 International scientific and technological societies and associations and a team of 30,000 eminent scholars, reputed scientists as editorial board members.
Stem Cell Congress-2018 will encompass recent researches and findings in stem cell technologies, stem cell therapies and transplantations, current understanding of cell plasticity in cancer and other advancements in stem cell research and cell science. Stem Cell Congress-2018 will be a great platform for research scientists and young researchers to share their current findings in this field of applied science. The major scientific sessions in Stem Cell Congress-2018 will focus on the latest and exciting innovations in prominent areas of stem cell and regenerative medicine research.
Conference Series LLC LTD invites all the participants from all over the world to attend 10th Annual Conference on Stem Cell and Regenerative Medicine during October 08-09, 2018 at Zurich, Switzerland which includes prompt keynote presentations, oral talks, poster presentations, networking, and exhibitions.
Track : Stem Cell
An undifferentiated cell of a multicellular creature which is fit for offering to ascend to inconclusively more cells of the same sort, and from which certain different sorts of cell emerge by separation. The most entrenched and generally utilized undifferentiated organism treatment is the transplantation of blood foundational microorganisms to treat infections and states of the blood and invulnerable framework or to restore the blood framework after medications for particular growths. Subsequent to the 1970s, skin undifferentiated organisms have been utilized to develop skin joins for patients with serious smolders on expansive territories of the body. Just a couple of clinical focuses can do this treatment and it is normally held for patients with life-debilitating blazes. It is likewise not a flawless arrangement: the new skin has no hair follicles or sweat organs. Research went into enhancing the strategy is continuous.
Track : Stem Cell Niche
A stem-cell niche is an area of a tissue that provides a specific microenvironment, in which stem cells are present in an undifferentiated and self-renewable state. Cells of the stem-cell niche interact with the stem cells to maintain them or promote their differentiation. The general niche model involves the association between resident stem cells and heterologous cell types—the niche cells.
Track : Induced Pluripotent Stem Cells
iPSC is derived from skin or blood cells that have been reprogrammed back into an embryonic-like pluripotent state that enables the development of an unlimited source of any type of human cell needed for therapeutic purposes. The discovery of induced pluripotent stem cells (iPSCs) has opened up unprecedented opportunities in the pharmaceutical industry, in the clinic, and in laboratories. In particular, the medical applications of human iPSCs in disease modeling and stem cell therapy have been progressing rapidly. The ability to induce cell fate conversion is attractive not only for these applications but also for basic research fields, such as development, cancer, epigenetics, and aging.
Track : Mesenchymal Stem Cells
Mesenchymal stem cells (MSCs) are adult stem cells traditionally found in the bone marrow. However, mesenchymal stem cells can also be isolated from other tissues including cord blood, peripheral blood, fallopian tube, and fetal liver and lung. Multipotent stem cells, MSCs differentiate to form adipocytes, cartilage, bone, tendons, muscle, and skin. Mesenchymal stem cells are a distinct entity to the mesenchyme, embryonic connective tissue which is derived from the mesoderm and differentiates to form hematopoietic stem cells.
Track : Cancer Stem Cells
Cancer stem cells (CSCs) are cancer cells (found in tumors or hematological cancers) that possess characteristics associated with normal stem cells. CSCs may generate tumors through the stem cell processes of self-renewal and differentiation into multiple cell types. Such cells are hypothesized to persist in tumors as a distinct population and cause relapse and metastasis by giving rise to new tumors. Therefore, development of specific therapies targeted at CSCs holds hope for improvement of survival and quality of life of cancer patients, especially for patients with metastatic disease.
Track : Hematopoietic Stem Cells
Hematopoietic stem cells (HSCs) are multipotent, self-renewing progenitor cells that develop from mesodermal hemangioblast cells. All differentiated blood cells from the lymphoid and myeloid lineages arise from HSCs. HSCs can be found in the adult bone marrow, peripheral blood, and umbilical cord blood. More recent advances have resulted in the use of HSC transplants in the treatment of cancers and other immune system disorders.
Track : Embryonic Stem Cells
Embryonic Stem Cells are immortal cells having an almost unlimited developmental potential. These are made from cells found in very early human embryos, called blastocysts. Many scientists are working how to create specialized cell types found in the body by exposing Embryonic Stem Cells to different conditions which they can use to treat numerous different diseases, like multiple sclerosis, blindness, and diabetes.
Track : Adult Stem Cells
Adult stem cells are undifferentiated cells found throughout the body that divides to replenish dying cells and regenerate damaged tissues. Adult stem cell treatments have been used for many years to treat successfully leukemia and related bone/blood cancers through bone marrow transplants.
Scientific interest in adult stem cells is centered on their ability to divide or self-renew indefinitely, and generate all the cell types of the organ from which they originate, potentially regenerating the entire organ from a few cells.
Track : Stem Cell Therapy
Stem cell therapy is used to treat or prevent diseases by using stem cells. It has potential in a wide range of territories of potential and restorative examination. This treatment is by and large used to supplant or repair harmed cells or tissues. It additionally helps in transplanting immature microorganisms or giving medications those objective undifferentiated organisms as of now in the body. Undeveloped cell treatment is a rising innovation; the recovery of the body part is not really another idea.
Track : Stem Cell Transplantation
Stem cell transplantation, also referred to as bone marrow transplant, in which unhealthy blood-forming cells replace with healthy cells. Stem cell transplantation in combination with doses of chemotherapy or radiation therapy increases the chance of eliminating blood cancer in the marrow. Many researchers are working to improve stem cell transplantation procedures to make it an option for patients.arrangement: the new skin has no hair follicles or sweat organs. Research went into enhancing the method is progressing.
Track : Somatic Cell Therapy
Somatic cell treatment is the organization to people of autologous, allogeneic, or xenogeneic living cells which have been controlled or prepared ex vivo. Assembling of items for substantial cell treatment includes the ex vivo proliferation, development, choice. Substantial cell treatment is seen as a more moderate, more secure methodology since it influences just the focused on cells in the patient, and is not went on to future eras. Substantial quality treatment speaks to standard essential and clinical exploration, in which helpful DNA (either incorporated in the genome or as an outside episome or plasmid) is utilized to treat illness. Most concentrate on the extreme hereditary issue, including immunodeficiencies, hemophilia, thalassemia and cystic fibrosis. Such single quality issue is the great possibility for substantial cell treatment.
Track : Regenerative Medicine
Organ and tissue loss through disease and injury motivate the development of therapies that can regenerate tissues and decrease reliance on transplantations. Regenerative medicine, an interdisciplinary field that applies engineering and life science principles to promote regeneration, can potentially restore diseased and injured tissues and whole organs.
Track : Tissue Regeneration
Tissue Engineering is the investigation of the development of new connective tissues, or organs, from cells and a collagenous platform to create a completely useful organ for implantation over into the contributor host. Effective improvements in the multidisciplinary field of tissue building have created a novel arrangement of tissue new parts and execution approaches. Investigative advances in biomaterials, foundational microorganisms, development and separation components, and biomimetic situations have made special chances to manufacture tissues in the research facility from blends of designed extracellular networks cells and organically dynamic particles.
Track : Regeneration and Therapeutics
Tissue regeneration therapeutics, making foundational microorganisms for supportive application in regenerative pharmaceutical. A regenerative solution is to offer the body some help with recuperating itself more sufficiently. It also develops OsteoScaf, a biodegradable, fully resorbable, and osteoconductive scaffold for use in healing tissue defects. In regenerative pharmaceutical, cell, tissue and organ substitutes are made to restore normal limit that has been lost.
Track : Stem Cell Apoptosis and Signal Transduction
Self-replication and proliferation of stem cell populations are controlled, by induction of apoptosis. The number of stem cells is, therefore, a balance between those lost to differentiation/apoptosis and those gained through proliferation. Apoptosis of stem cells is believed to be a dynamic process which changes in response to environmental conditions. For example, the release of stem cell factor inhibits apoptosis following spinal cord injury, presumably in an attempt to promote tissue repair. Dysregulation of apoptosis in stem cells is believed to underlie some cancer pathologies, where apoptotic resistance results in uncontrolled growth (i.e. glioblastoma). Controlling apoptosis is also an important focus for studies of stem cell transplantation, where inhibition may increase the survival of grafted cells during replacement therapy. Harnessing the full therapeutic potential of stem cells will require full elucidation of the signal transduction cascades for proliferation, differentiation, and apoptosis.
Track : Immunological Challenges for Stem Cells
Stem cells have a huge potential for treating disease but one challenging area is that involving a patient's immune system. Also, the increasing numbers of stem cell therapies are entering clinical trials and the issue of the immunological consequences are also unusual and it's important to understand what exactly happens during immune rejection before looking at the different immunological consequences from the use of embryonic stem cells.
Track: Computational Stem Cell Biology & Systems Biology
Computational Biology sometimes referred to as bioinformatics, is the science of using biological data to develop algorithms and relations among various biological systems. Bioinformatics groups use computational methods to explore the molecular mechanisms underpinning stem cells. To accomplish this bioinformatics develop and apply advanced analysis techniques that make it possible to dissect complex collections of data from a wide range of technologies and sources.
Track : Novel Stem Cell Technologies
Stem cell technology is a rapidly developing field that combines the efforts of cell biologists, geneticists, and clinicians and offers hope of effective stem cell treatment for a variety of malignant and non-malignant diseases. Stem cells are defined as totipotent progenitor cells capable of self-renewal and multilineage differentiation. Most development is in developing cell culture media, cell separation products, instruments and other reagents for use in stem cell immunology, cancer, regenerative medicine and cellular therapy research.
Track : Stem Cell BioBanking & Tissue Preservation
Stem cell banking through long-term storage of different stem cell platforms represents a fundamental source to preserve original features of stem cells for patient-specific clinical applications. Stem cell research and clinical translation constitute fundamental and indivisible modules catalyzed through biobanking activity, generating a return of investment.
Track : Biomaterials & Stem Cells
Biomaterials and stem cell has the potential for the treatment of diseases to the repair and regeneration of the organs. Modern stem cells in regenerative medicine are mainly using three-dimensional structured biomaterials in combination with stem cells as a cell source. Biomaterial scaffolds are developed that not only serve as cell carriers providing mechanical support, but actively influence cellular responses including cell attachment and proliferation. Researchers are working in the field of identification of biomaterials which is most suitable for stem cells in regenerative medicine.
Track : 3D Bioprinting & Biofabrication
3D Bioprinting aids stem cells in tissue engineering by providing an in-depth information of the image and structure analysis of the image. Biofabrication is referred to the production of artificial tissues or organs to address health challenges in medicine. It often uses the principle of 3D Bioprinting to form cells, gels, and fibers into an organ.
Please contact the event manager Marilyn (firstname.lastname@example.org ) below for:
- Multiple participant discounts
- Price quotations or visa invitation letters
- Payment by alternate channels (PayPal, check, Western Union, wire transfers etc)
- Event sponsorships
NO REFUNDS ALLOWED ON REGISTRATIONS
Service fees included in this listing.
This event is brought to you by:
Conference Series - NewYorkEventsList
Kirchensteig, Glattpark, Opfikon, Bezirk Bülach, Zürich, 8050, Schweiz/Suisse/Svizzera/Svizra
Sind Sie ein Veranstalter?
Die Veranstaltung wird interessierten Benutzern empfohlen.
An diesen Event interessiert?
Sind Sie ein Veranstalter?
Die Veranstaltung wird interessierten Benutzern empfohlen.